At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...
Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners' clinical development, recently presented its Next-Generation LNP advancements, a ...
Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - ...
Q3 2025 Earnings Call Transcript November 6, 2025 Viatris Inc. beats earnings expectations. Reported EPS is $0.67, expectations were $0.63. Operator: Good morning, and welcome to the Viatris Q3 2025 ...
Key presentation unveiled Acuitas' Next-Generation LNP Advancements, which is designed to enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic impact ...
It’s possible to contract HIV through oral sex, although it’s less common than contracting HIV through vaginal or anal sex. Medications, condoms, and dental dams are all methods that can help prevent ...
Oral cancer is a cancerous growth in the mouth, on the tongue, lips or gums. The most common type of oral cancer is squamous cell carcinoma. Adeoye et al. develop a multivariable risk prediction model ...
Dentists have long suspected a link between oral hygiene and cardiovascular health. Today, research confirms that the connection is real, and more important than once believed. Our mouths aren’t ...
Analgesia for dehorning calves has been a somewhat controversial subject since I can remember. We learned in vet school about lidocaine infiltration with needles including nerve blocks and/or whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback